Last price paid | n.a. | |
Change | -28.57% [ -0.09 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | n.a. n.a. |
Fixing | n.a. |
Settlement date | 24.11.2022 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | -83.58% |
Year to date (YTD) | -61.54% |
1 month | -56.31% |
3 months | -40.00% |
1 year | -81.01% |
3 years | n.a. |
Issue price | 1.37 |
Underlying price on issue | 83.33 |
Premium | -0.06% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1206985801 |
Symbol | INOELZ |
Security | 120698580 |
Exchange | ZKB |
Currency | CHF |
Expiry | n.a. |
Underlying | Novartis N, CH0012005267 |
Underlying ISIN | CH0012005267 |
Funding level | 98.715600 |
Stop-loss level | 95.760600 |
Distance to stop-loss level | 6.59% |
Long/Short type | Short |
Subscription ratio | 14.99 |
Issuer | Zuercher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 22.11.2022 |
Premium | -6.13% |
Premium p.a. | n.a. |
Leverage | 26.63 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 8.879000 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
Swiss Re | 109.25 |
UBS | 26.36 |
LOGITECH INT. | 78.12 |
NOVARTIS N | 99.37 |
SONOVA HLDG N | 291.70 |
Name | Price |
---|---|
Lonza Group | 549.00 |
Compagnie Financi... | 132.60 |
KUEHNE & NAGEL | 257.10 |
ROCHE GS | 281.00 |
GEBERIT N | 518.00 |